Revenues up 7.2% on the prior-year quarter to EUR 356.5m Adjusted EBITDA at EUR 74.2m in second quarter of 2019 (Q2 2018: EUR 71.1m), excluding EUR 26.2m from...
Duesseldorf, May 14, 2019 – Dr. Bernd Metzner (48) takes up the position of Chief Financial Officer of Gerresheimer AG on May 15, 2019. Dr. Metzner had been...
Revenues up 6.3% on the prior-year quarter to EUR 308.5m Adjusted EBITDA at EUR 145.9m in first quarter of 2019 (Q1 2018: EUR 52.6m), comprising of EUR 53.6m...
Düsseldorf/Olten, July 03, 2019 – Developed specially by Sensile Medical for EVER Pharma under the brand name D-mine®, this wearable micro-infusion pump...
Gerresheimer Essen welcomes its new apprenticesDüsseldorf/Essen, August 14, 2019. General Manager of Gerresheimer Essen GmbH, Dr. Jürgen Unruh, warmly greets...
Images of the
Gerresheimer
